Elutia (ELUT) News Today $2.74 +0.08 (+2.82%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™March 28 at 3:23 AM | markets.businessinsider.comElutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluProâ„¢March 27 at 4:14 PM | globenewswire.comElutia publishes new preclinical data in AntibioticsMarch 27 at 9:56 AM | markets.businessinsider.comElutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic EnvelopeMarch 25 at 4:05 PM | globenewswire.comElutia files $100M mixed securities shelfMarch 18, 2025 | markets.businessinsider.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Drops By 29.8%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 67,700 shares, a decline of 29.8% from the February 13th total of 96,400 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average trading volume of 41,100 shares, the short-interest ratio is presently 1.6 days.March 17, 2025 | marketbeat.comInsider Buying: Elutia Inc. (NASDAQ:ELUT) Director Buys 420,000 Shares of StockElutia Inc. (NASDAQ:ELUT - Get Free Report) Director Highcape Capital, L.P. purchased 420,000 shares of the company's stock in a transaction dated Monday, February 3rd. The shares were acquired at an average price of $2.50 per share, for a total transaction of $1,050,000.00. Following the purchase, the director now directly owns 9,520,232 shares of the company's stock, valued at approximately $23,800,580. The trade was a 4.62 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.March 14, 2025 | marketbeat.comElutia Inc. (NASDAQ:ELUT) Director Acquires $1,050,000.00 in StockMarch 14, 2025 | insidertrades.comElutia Inc. Q4 Loss DecreasesMarch 8, 2025 | nasdaq.comEarnings call transcript: Elutia Q4 2024 misses forecasts, stock dropsMarch 8, 2025 | uk.investing.comElutia Inc. (NASDAQ:ELUT) Q4 2024 Earnings Call TranscriptMarch 8, 2025 | msn.comElutia (NASDAQ:ELUT) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and issued a $8.00 price objective on shares of Elutia in a research report on Friday.March 8, 2025 | marketbeat.comQ4 2024 Elutia Inc Earnings CallMarch 7, 2025 | finance.yahoo.comElutia reports Q4 EPS (26c) vs. (40c) last yearMarch 7, 2025 | markets.businessinsider.comElutia (NASDAQ:ELUT) Releases Quarterly Earnings ResultsElutia (NASDAQ:ELUT - Get Free Report) released its earnings results on Thursday. The company reported ($0.26) EPS for the quarter.March 7, 2025 | marketbeat.comElutia Inc. (ELUT) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comElutia Inc. Reports 18% Increase in BioEnvelope Sales Driven by EluPro CommercializationMarch 6, 2025 | quiverquant.comElutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-OutMarch 6, 2025 | globenewswire.comElutia Inc. (NASDAQ:ELUT) Short Interest UpdateElutia Inc. (NASDAQ:ELUT - Get Free Report) saw a significant increase in short interest in February. As of February 15th, there was short interest totalling 96,400 shares, an increase of 62.3% from the January 31st total of 59,400 shares. Approximately 0.4% of the shares of the company are short sold. Based on an average trading volume of 41,300 shares, the days-to-cover ratio is currently 2.3 days.March 2, 2025 | marketbeat.comElutia (NASDAQ:ELUT) Stock Price Down 5.4% - Time to Sell?Elutia (NASDAQ:ELUT) Shares Down 5.4% - Time to Sell?March 1, 2025 | marketbeat.comElutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025February 20, 2025 | globenewswire.comPrivate equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9mFebruary 8, 2025 | finance.yahoo.comElutia Inc. secures $15 million through stock and warrant saleFebruary 3, 2025 | msn.comElutia launches $15M securities offeringFebruary 3, 2025 | msn.comElutia Announces Direct Offering - Quick FactsFebruary 3, 2025 | markets.businessinsider.comElutia Announces $15.0 Million Registered Direct OfferingFebruary 3, 2025 | globenewswire.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Increases By 29.8%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 67,000 shares, an increase of 29.8% from the December 31st total of 51,600 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily volume of 40,300 shares, the days-to-cover ratio is presently 1.7 days.February 1, 2025 | marketbeat.comFY2024 EPS Estimates for Elutia Raised by Cantor FitzgeraldElutia Inc. (NASDAQ:ELUT - Free Report) - Analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for Elutia in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will earn ($1.74) per share for the year, upJanuary 23, 2025 | marketbeat.comBrokers Offer Predictions for Elutia FY2025 EarningsElutia Inc. (NASDAQ:ELUT - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Elutia in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company will earn (January 22, 2025 | marketbeat.comElutia announces full U.S. commercial launch of EluProJanuary 14, 2025 | markets.businessinsider.comElutia Announces Full Launch of EluPro™ Following Strong Initial DemandJanuary 14, 2025 | markets.businessinsider.comElutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing PartnersJanuary 6, 2025 | markets.businessinsider.comElutia Inc. (ELUT)December 24, 2024 | finance.yahoo.comElutia (NASDAQ:ELUT) Trading Up 1.9% - Here's WhyElutia (NASDAQ:ELUT) Trading 1.9% Higher - Time to Buy?December 7, 2024 | marketbeat.comElutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.December 2, 2024 | finance.yahoo.comElutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 17, 2024 | uk.finance.yahoo.comQ3 2024 Elutia Inc Earnings CallNovember 15, 2024 | finance.yahoo.comElutia Inc. Reports Strong Q3 Results, Prepares for Major Product LaunchNovember 15, 2024 | markets.businessinsider.comElutia's (ELUT) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $10.00 price target on shares of Elutia in a report on Friday.November 15, 2024 | marketbeat.comElutia reports Q3 EPS (33c) vs (57c) last yearNovember 14, 2024 | markets.businessinsider.comElutia Inc. (ELUT) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comElutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025November 14, 2024 | markets.businessinsider.comElutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 13, 2024 | markets.businessinsider.comElutia (ELUT) Set to Announce Quarterly Earnings on ThursdayElutia (NASDAQ:ELUT) will be releasing earnings after the market closes on Thursday, November 14, Zacks reports.November 12, 2024 | marketbeat.comElutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30October 23, 2024 | globenewswire.comSILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia IncOctober 15, 2024 | finance.yahoo.comNantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT)Nantahala Capital Management LLC lifted its stake in Elutia Inc. (NASDAQ:ELUT - Free Report) by 8.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,795,697 shares of the company's stock after buying an additional 14October 1, 2024 | marketbeat.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 70,500 shares, a decrease of 30.1% from the August 31st total of 100,800 shares. Based on an average trading volume of 69,100 shares, the short-interest ratio is currently 1.0 days. Currently, 0.4% of the shares of the stock are sold short.September 27, 2024 | marketbeat.comECU Health pioneers with FDA-approved EluPro BioEnvelope in pacemaker implantationSeptember 21, 2024 | msn.comElutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable DevicesSeptember 18, 2024 | globenewswire.com Remove Ads Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address ELUT Media Mentions By Week ELUT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELUT News Sentiment▼0.580.78▲Average Medical News Sentiment ELUT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELUT Articles This Week▼61▲ELUT Articles Average Week Remove Ads Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AUTL News Today TRML News Today STOK News Today ALT News Today DNA News Today ZVRA News Today RGNX News Today PHAT News Today SIGA News Today ERAS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELUT) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elutia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.